]>
IRCT20221001056065N1 IRCT 2022-11-07 Mashhad University of Medical Sciences Efficacy evaluation of the Melissa officinalis syrup in treatment of children's anxiety symptoms with Attention Deficit Hyperactivity Disorder Efficacy evaluation of the Melissa officinalis syrup in treatment of children's anxiety symptoms with Attention Deficit Hyperactivity Disorder 2022-11-01 anticipated 30 Complete https://irct.ir/trial/66256 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Block randomization using https://www.sealedenvelope.com Allocation Concealment method: To ensure equal number of study subjects in two groups, permutation block method was used. For this purpose, we will use the website www.sealedenvelope.com in such a way that the number of 8 blocks of 4 members will be randomly created through the above site, Blinding description: Sealed envelopes. 2-3 Attention Deficit Hyperactivity Disorder. Intervention 1: Intervention group: Melissa officinalis syrup of Ehyateb Daru Tabiat company with a dose of 0.2 cc per kilogram of weight in two divided doses recipients. Intervention 2: Control group: Placebo syrup with a dose of 10 cc per day in two doses recipients. Yes - There is a plan to make this available What will be shared: After completing the study and obtaining permission from the Research Vice-Chancellor of Mashhad University of Medical Sciences, the researchers are ready to publish the results of the study in the form of an article. When: After the completion of the project (about one year after starting the work) and the resident's defense of his/her thesis, the researchers are ready to publish the results. To whom: Officials of Mashhad University of Medical Sciences and, therapists working in the field of mental health Conditions: For the purpose of clinical use of the obtained results in the treatment of patients and in the event of the absence of clinical complications during the research Where to obtain: Mashhad University of Medical Sciences, Research department How to obtain: Refer to research unit of Mashhad Medical Sciences Faculty, Dissertations Unit and obtain access permission Comments:
public Fatemeh Moharari
Horameli St
Mashhad Iran (Islamic Republic of) 919583134 +98 51 3700 2202 MoharariF1@mums.ac.ir Mashhad University of Medical Sciences scientific Fatemeh Moharari
Horameli St
Mashhad Iran (Islamic Republic of) 919583134 +98 51 3700 2202 MoharariF1@mums.ac.ir Mashhad University of Medical Sciences Iran (Islamic Republic of) The patient with DSM V ADHD criteria, Absence of other systemic or psychiatric disorders, IQ in the normal range at least three months have passed since their standard drug treatment, Completion of the informed consent form by the parent 7 years 12 years Both F90.0 Attention-deficit hyperactivity disorder, predominantly inattentive type Treatment - Drugs Placebo Intervention group: Melissa officinalis syrup of Ehyateb Daru Tabiat company with a dose of 0.2 cc per kilogram of weight in two divided doses recipients Control group: Placebo syrup with a dose of 10 cc per day in two doses recipients Revised Children's Anxiety Scale. Timepoint: in 3 and 6 weeks. Method of measurement: The amount of change in the revised children's anxiety scale questionnaire. Attention deficit hyperactivity disorder scoring scale questionnaires. Timepoint: in 3 and 6 weeks. Method of measurement: The amount of change in attention deficit hyperactivity disorder scoring scale. Revised Children's Manifest Anxiety Scale score. Timepoint: week 3 and 6. Method of measurement: The amount of change in the anxiety score. Mashhad University of Medical Sciences Approved 2022-07-26 School of Medicine, Mashhad University of Medical Sciences Horameli St., Ibn Sina Hospital Mashhad Razavi Khorasan Iran (Islamic Republic of)